Ticker: AKRO

Company: Akero Therapeutics, Inc.

Person: Timothy Rolph, officer

Transaction date: Sept. 11, 2025

Reporting date: Sept. 12, 2025

Average share price: 43.02

Sold 553.0 shares for 23790.06